Branford, CT, United States of America

Luka Djapic

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Isoplexis Corporation. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Luka Djapic: Innovator in Biological Analysis Systems

Introduction

Luka Djapic is a notable inventor based in Branford, CT (US). He has made significant contributions to the field of biological analysis through his innovative work. His expertise and dedication to advancing technology have led to the development of a unique patent.

Latest Patents

Luka Djapic holds a patent for "Systems, devices and methods for multiplexed analysis." This patent focuses on systems, methods, and apparatus for the multiplexed analysis of biological material. The apparatus includes an assembly with a first frame featuring multiple openings, a capture agent slide, and a channel membrane. This invention aims to enhance the efficiency and accuracy of biological material analysis.

Career Highlights

Luka Djapic is currently associated with Isoplexis Corporation, where he applies his innovative ideas to real-world applications. His work at Isoplexis Corporation reflects his commitment to improving biological analysis technologies. His contributions have been instrumental in advancing the capabilities of the company.

Collaborations

Luka has collaborated with talented individuals such as Benjamin Ports and Igor Nikonorov. These collaborations have fostered a creative environment that encourages innovation and the development of cutting-edge technologies.

Conclusion

Luka Djapic is a distinguished inventor whose work in multiplexed analysis systems has the potential to revolutionize biological material analysis. His patent and contributions to Isoplexis Corporation highlight his role as a key player in the field of innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…